TEGSEDI

inotersen · Akcea Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TEGSEDI, covering 2024-01-17 to 2026-06-04. Get the full timeline:

Most recent: EMA Authorised: Tegsedi (inotersen sodium) — Akcea Therapeutics Ireland Limited